Published in J Rheumatol on March 01, 1997
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther (2009) 3.47
Ankylosing spondylitis: an overview. Ann Rheum Dis (2002) 2.71
Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis (2002) 1.32
Epidemiology of spondyloarthritis. Rheum Dis Clin North Am (2012) 1.01
Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol (2010) 1.00
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci (2013) 0.93
Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol (2005) 0.92
Urolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI). Caspian J Intern Med (2012) 0.84
An epidemiological study on ankylosing spondylitis in southern Albania. Mater Sociomed (2014) 0.83
Time trends in incidence, clinical features, and cardiovascular disease in ankylosing spondylitis over three decades: a population-based study. Arthritis Care Res (Hoboken) (2015) 0.83
Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS. BMJ Open (2014) 0.80
The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study. Arthritis Res Ther (2015) 0.80
The prevalence of moderate to severe radiographic sacroiliitis and the correlation with health status in elderly Swedish men--the MrOS study. BMC Musculoskelet Disord (2013) 0.79
Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study. Cost Eff Resour Alloc (2015) 0.77
MRI of cervical spine injuries complicating ankylosing spondylitis. Skeletal Radiol (2008) 0.75
Fluoroscopy-guided Intra-articular Sacroiliac Joint Steroid Injection for Sacroiliitis in Ankylosing Spondylitis: A Case Report. West Indian Med J (2014) 0.75
Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1). Arthritis Rheumatol (2016) 0.75
Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting. Perm J (2016) 0.75
Survival of disease-modifying antirheumatic drugs used as the first antirheumatic medication in the treatment of ankylosing spondylitis in Finland. A nationwide population-based register study. Clin Rheumatol (2014) 0.75
Incidence of inflammatory joint diseases in Finland: results from a population-based epidemiological study. Rheumatol Int (2017) 0.75
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum (2000) 6.88
Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ (1980) 5.66
HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease. Arthritis Rheum (1974) 4.28
Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand (1969) 4.03
Smoking and risk of rheumatoid arthritis. J Rheumatol (1993) 3.63
Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch Intern Med (1998) 3.01
Marked cross-agglutination between Brucellae and a subtype of Yersinia enterocolitica. Acta Pathol Microbiol Scand (1969) 2.57
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Increased incidence of alcohol-related deaths from accidents and violence in subjects with ankylosing spondylitis. Br J Rheumatol (1998) 2.28
Studies of syphilitic antibodies. I. Anti-lipoidal antibodies in various stages of syphilis. Br J Vener Dis (1967) 2.07
HL-A antigen 27 and reactive arthritis. Lancet (1973) 2.07
Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol (1995) 1.96
Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease. Arthritis Rheum (1992) 1.90
Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol (1986) 1.88
Physical exercise and risk of severe knee osteoarthritis requiring arthroplasty. Rheumatology (Oxford) (2001) 1.78
Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis (2000) 1.74
Chlamydia trachomatis in acute salpingitis. Br J Vener Dis (1979) 1.69
Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol (1995) 1.66
Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology (Oxford) (1999) 1.53
Joint symptoms and diseases associated with moisture damage in a health center. Clin Rheumatol (2003) 1.51
When does rheumatoid disease start? Arthritis Rheum (1985) 1.50
Smoking, lung function, and rheumatoid factors. Ann Rheum Dis (1990) 1.43
Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology (Oxford) (1999) 1.43
Validity of hospital discharge data in a prospective epidemiological study on stroke and myocardial infarction. Acta Med Scand (1984) 1.43
Anticardiolipin response in acute infections. Clin Immunol Immunopathol (1986) 1.39
Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol (1995) 1.37
Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet (1993) 1.34
Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology (2001) 1.28
Is the report of widespread body pain associated with long-term increased mortality? Data from the Mini-Finland Health Survey. Rheumatology (Oxford) (2006) 1.27
Rheumatoid factor, chronic arthritis and mortality. Ann Rheum Dis (1995) 1.26
Mortality in rheumatoid arthritis. Semin Arthritis Rheum (1995) 1.26
Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis (1994) 1.24
Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990. Clin Exp Rheumatol (1997) 1.24
Experimentally induced mononucleosis-like heterophile antibodies in man. Clin Exp Immunol (1969) 1.22
Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation (1995) 1.21
Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun (2005) 1.19
Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol (1991) 1.19
Reactive arthritis. Clin Rheum Dis (1985) 1.18
Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol (1998) 1.17
Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med (1994) 1.15
Yersinia reactive arthritis. Br J Rheumatol (1983) 1.15
Serum HI antibody and protection against influenza: a follow-up survey at community level of three epidemics caused by different H3N2-variants. Int J Epidemiol (1975) 1.14
Early-onset osteoarthritis linked to the type II procollagen gene. Detailed clinical phenotype and further analyses of the gene. Arthritis Rheum (1993) 1.14
Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol (1995) 1.13
Incidence of chronic inflammatory joint diseases in Finland in 1995. J Rheumatol (2000) 1.12
Incidence of rheumatoid arthritis in Finland during 1980-1990. Ann Rheum Dis (1996) 1.10
Seroepidemiology of H1N1 influenza: striking differences in the attack rate among young people. Acta Pathol Microbiol Scand B (1979) 1.09
False-positive serological test for syphilis in pregnancy. Acta Derm Venereol (1969) 1.08
Rheumatoid factor and immuno-conglutinin responses following various vaccinations. Proc Soc Exp Biol Med (1967) 1.08
Studies of syphilitic antibodies. II. Substances responsible for biological false positive sero-reactions. Br J Vener Dis (1968) 1.07
[Rheumatoid arthritis shortens life]. Duodecim (1995) 1.07
Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis. Ann Rheum Dis (2001) 1.07
Measuring rheumatoid factor in nonrheumatoid subjects: immunoturbidimetric assay, latex slide test, and enzyme-linked immunosorbent assay compared. Clin Chem (1991) 1.05
Twin studies in rheumatic diseases. Semin Arthritis Rheum (1994) 1.02
Association of infection with Chlamydia trachomatis with Fitz-Hugh-Curtis syndrome. J Infect Dis (1981) 1.02
Serum cholesterol and risk of rheumatoid arthritis in a cohort of 52 800 men and women. Br J Rheumatol (1996) 1.02
Symptomless autoimmune thyroiditis in coronary heart-disease. Lancet (1972) 1.01
[Emergence of multidrug resistant Salmonella strains in Lome (Togo)]. Med Mal Infect (2007) 1.00
Filaggrin related antibodies among the aged. Ann Rheum Dis (2003) 0.99
Multiple sclerosis in a nationwide series of twins. Neurology (1987) 0.99
Virus antibody levels in IgA deficiency. Scand J Immunol (1976) 0.98
Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study. Cancer (1999) 0.98
Ischaemic cerebrovascular disease in young adults. 1. Smoking habits, use of oral contraceptives, relative weight, blood pressure and electrocardiographic findings. Acta Neurol Scand (1973) 0.97
Prospect for an additional laboratory criterion for rheumatoid arthritis. Scand J Rheumatol (1993) 0.97
[Incidence of stroke in Finland]. Duodecim (1974) 0.97
Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis. Epidemiology (2000) 0.96
The order of appearance of reactivity to treponemal and lipoidal tests in early syphilis. Acta Pathol Microbiol Scand (1967) 0.96
C-reactive protein in population samples. Acta Med Scand (1986) 0.96
Parity and risk of rheumatoid arthritis in Finnish women. Br J Rheumatol (1995) 0.94
Seroepidemiology of H1N1 influenza: the infection and re-infection rate in winter 1978-79. J Hyg (Lond) (1981) 0.94
Prevalence of stroke in Finland. Stroke (1986) 0.94
Effect of interferon on plasma lipoproteins and on the activity of postheparin plasma lipases. Arteriosclerosis (1982) 0.93
The distribution of class-specific rheumatoid factors is similar in rheumatoid and pre-illness sera. Scand J Immunol (1986) 0.93
Studies of false positive serological tests for syphilis following smallpox vaccination. Ann Med Exp Biol Fenn (1966) 0.92
Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol (1996) 0.91
Studies of gamma-G red cell heteroantibodies in normal and in mononucleosis serum. Int Arch Allergy Appl Immunol (1967) 0.91
Family study of Reiter's disease and HLA B27 distribution. J Rheumatol (1977) 0.90
Screening for HIV antibody during pregnancy. Lancet (1987) 0.90
Radiographic remission in seropositive rheumatoid arthritis. A 20-year follow-up study. Clin Exp Rheumatol (2001) 0.90
Serologic response against cardiolipin and enterobacterial common antigen in young patients with acute myocardial infarction. Clin Immunol Immunopathol (1989) 0.89
Antibodies against native type II collagen do not precede the clinical onset of rheumatoid arthritis. Arthritis Rheum (1988) 0.89
Quantitative Reiter protein complement-fixation test. Br J Vener Dis (1967) 0.89
Multiallelic polymorphism of the cartilage collagen gene: no association with osteoarthrosis. Ann Rheum Dis (1993) 0.89
Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. J Rheumatol (1990) 0.89
Tests for syphilis in young males. An analysis of a seven-year series from a Central Military Hospital. Mil Med (1967) 0.88
Magnitude of the genetic component in juvenile idiopathic arthritis. Ann Rheum Dis (2000) 0.88
Smoking history and serum cotinine and thiocyanate concentrations as determinants of rheumatoid factor in non-rheumatoid subjects. Rheumatology (Oxford) (2004) 0.88
Uveitis as a cause of visual loss in arthritides and comparable conditions. J Rheumatol (2001) 0.88
Pneumatic tourniquet paralysis. Case report. J Bone Joint Surg Br (1983) 0.88
Incidence of stroke in a Finnish prospective population study. Stroke (1986) 0.88
Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost (1996) 0.88
Seropositive versus seronegative rheumatoid arthritis--time for a new definition. J Rheumatol (1994) 0.88
Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: an increased prevalence of disease in MZ twins and concordance of disease features. J Intern Med (1992) 0.87
Declining incidence and mortality rates of stroke in Finland from 1972 to 1991. Results of three population-based stroke registers. Stroke (1996) 0.87
Immune responses in yersinia-associated reactive arthritis. Ann Rheum Dis (1979) 0.87
Serum androgen-anabolic hormones and the risk of rheumatoid arthritis. Ann Rheum Dis (1998) 0.87
Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis. Br J Rheumatol (1995) 0.87
Rheumatoid factor seroconversions in relation to clinical rheumatoid arthritis. Ann Clin Res (1985) 0.86
Significance of rheumatoid factors in an eight-year longitudinal study on arthritis. Rheumatol Int (1988) 0.86
HLA B27: a prognostic factor in juvenile chronic arthritis. Clin Rheumatol (1998) 0.86